Correlation Between Akari Therapeutics and NextCure
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and NextCure, you can compare the effects of market volatilities on Akari Therapeutics and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and NextCure.
Diversification Opportunities for Akari Therapeutics and NextCure
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Akari and NextCure is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and NextCure go up and down completely randomly.
Pair Corralation between Akari Therapeutics and NextCure
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to generate 1.8 times more return on investment than NextCure. However, Akari Therapeutics is 1.8 times more volatile than NextCure. It trades about -0.08 of its potential returns per unit of risk. NextCure is currently generating about -0.16 per unit of risk. If you would invest 243.00 in Akari Therapeutics PLC on November 2, 2024 and sell it today you would lose (108.00) from holding Akari Therapeutics PLC or give up 44.44% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Akari Therapeutics PLC vs. NextCure
Performance |
Timeline |
Akari Therapeutics PLC |
NextCure |
Akari Therapeutics and NextCure Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Akari Therapeutics and NextCure
The main advantage of trading using opposite Akari Therapeutics and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
NextCure vs. CytomX Therapeutics | NextCure vs. Spero Therapeutics | NextCure vs. Instil Bio | NextCure vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |